S. Yousuf Zafar, MD, Associate Professor of Medicine at Duke Cancer Institute, discusses the association of obesity with metastatic colorectal cancer.
Zafar and his team wanted to discover whether obesity has a role in survival for patients who have metastatic colorectal cancer (mCRC). They conducted an analysis of 4 pooled studies in over 6000 patients who were starting treating for mCRC.
Zafar and his team originally predicted that obese patients would be at a greater risk for the worst survival. However, study findings showed that, in fact, patients with the lowest BMI have the greater risk.
S. Yousuf Zafar, MD, Associate Professor of Medicine at Duke Cancer Institute, discusses the association of obesity with metastatic colorectal cancer.
Peritoneal RFS May Be a Stronger Predictor of OS in CRC Peritoneal Metastasis
March 27th 2024In an interview with Targeted Oncology, Muhammad Talha Waheed, MBBS, discussed research on the reliability of using recurrence-free survival as an efficacy end point for trials evaluating patients with colorectal cancer peritoneal metastasis.
Read More